• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Sidoti Events, LLC's Virtual June Small-Cap Conference

    6/11/24 10:50:00 AM ET
    $AGI
    $ALUR
    $ATOS
    $BRC
    Precious Metals
    Basic Materials
    Medical/Dental Instruments
    Health Care
    Get the next $AGI alert in real time by email

    NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day June Small-Cap Conference taking place Wednesday and Thursday, June 12-13, 2024. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.

    Presentation Schedule

    *All Times EDT

    Wednesday, June 12, 2024 (Day 1)

    8:30-9:00

    *****

    *****

    InfuSystem Holdings Inc. (INFU)

    *****

    9:15-9:45

    *****

    ECD Automotive (ECDA)

    Lifeward [ReWalk Robotics] (LFWD)

    *****

    10:00-10:30

    Unisys Corporation (UIS)

    *****

    Myomo, Inc (MYO)

    Drilling Tools International Corp. (DTI)

    10:45-11:15

    American Software (AMSWA)

    USANA Health Sciences (USNA)

    Assertio Holdings, Inc. (ASRT)

    Information Services Group ["ISG"] (III)

    11:30-12:00

    Vishay Precision Group (VPG)

    Global Industrial Company (GIC)

    Zomedica Corp. (ZOM)

    Charles River Associates (CRAI)

    12:15-12:45

    Quad/Graphics Inc (QUAD)

    *****

    RadNet, Inc. (RDNT)

    *****

    1:00-1:30

    *****

    Rayonier Advanced Materials ["RYAM"] (RYAM)

    Superior Group of Companies (SGC)

    Portman Ridge Finance Corp (PTMN)

    1:45-2:15

    *****

    Electromed (ELMD)

    Senseonics Holdings, Inc. (SENS)

    BioLargo, Inc. (BLGO)

    2:30-3:00

    A10 Networks, Inc. (ATEN)

    Granite Ridge Resources, Inc. (GRNT)

    Theravance Biopharma (TBPH)

    ARC Document Solutions (ARC)

    3:15-3:45

    GlucoTrack Inc. (GCTK)

    Canoo (GOEV)

    Bitcoin Depot (BTM)

    Topaz Energy Corp (TSX:TPZ)

    4:00-4:30

    Intelligent Bio Solutions (INBS)

    Brilliant Earth Group, Inc. (BRLT)

    Oportun Financial Corp. (OPRT)

    TrueBlue (TBI)

    1x1s Only

    (12th)

    GATX Corporation (GATX)

    Hillenbrand (HI)

    MYR Group Inc. (MYRG)

    Pitney Bowes (PBI)

    Primoris Services Corporation (PRIM)

    Sonendo (SONX)

    Titan International, Inc. (TWI)

    *****

    *All Times EDT

    Thursday, June 13, 2024 (Day 2)

    8:30-9:00

    GDEV Inc. (GDEV)

    *****

    Meihua Intl. Medical Technologies Co. (MHUA)

    *****

    9:15-9:45

    Commercial Vehicle Group (CVGI)

    Atossa Therapeutics (ATOS)

    Citius Pharmaceuticals, Inc. (CTXR)

    *****

    10:00-10:30

    Paysign, Inc. (PAYS)

    Graham Corporation (GHM)

    Allurion (ALUR)

    Mobile Infrastructure (BEEP)

    10:45-11:15

    *****

    Genco Shipping & Trading Ltd (GNK)

    VAREX IMAGING (VREX)

    Nature's Sunshine (NATR)

    11:30-12:00

    *****

    Brady Corporation (BRC)

    BioHarvest Sciences Inc. (CNVCD)

    Hovnanian Enterprises Inc (HOV)

    12:15-12:45

    *****

    Great Lakes Dredge & Dock Corp. (GLDD)

    *****

    CES Energy Solutions (CEU-TSX)

    1:00-1:30

    Sonim Technologies Inc. (SONM)

    Amerigo Resources (ARREF)

    *****

    The Real Brokerage Inc (REAX)

    1:45-2:15

    *****

    NN Inc. (NNBR)

    *****

    Consumer Portfolio Services (CPSS)

    2:30-3:00

    *****

    Alamos Gold Inc. (AGI)

    GoHealth (GOCO)

    Resources Connection, Inc. (RGP)

    1x1s Only

    (13th)

    Belden Inc. (BDC)

    CSW Industrials (CSWI)

    Federal Signal Corporation (FSS)

    HNI Corporation (HNI)

    OneSpan Inc. (OSPN)

    Plexus Corp. (PLXS)

    Sonendo (SONX)

    *****

    About Sidoti Events, LLC ("Events") and Sidoti & Company, LLC ("Sidoti")
    In 2023, Sidoti & Company, LLC (www.sidoti.com) formed an affiliate company, Sidoti Events, LLC in order to focus exclusively on its rapidly growing conference business and to more directly serve the needs of presenters and attendees. The relationship allows Events to draw on the 25 years of experience Sidoti has as a premier provider of independent securities research focused specifically on small and microcap companies and the institutions that invest in their securities, with most of its coverage in the $200 million-$5 billion market cap range. Sidoti's coverage universe comprises approximately 150 equities of which greater than 60 percent participate in the firm's rapidly growing Company Sponsored Research ("CSR") program. In 2024, Sidoti established Lighthouse Equity Research as an extension of its CSR program to meet the specific needs of companies not valued using traditional metrics or that face challenges obtaining coverage due to political risks or other factors. Events is a leading provider of corporate access through the eight investor conferences it hosts each year. By virtue of its direct ties to Sidoti, Event's benefits from Sidoti's small- and microcap-focused nationwide sales force, which has connections with 2,500 institutional relationships in North America. This enables Events to provide multiple forums for meaningful interaction for small and microcap issuers and investors specifically interested in companies in the sector.

    SOURCE: Sidoti Events, LLC



    View the original press release on accesswire.com

    Get the next $AGI alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGI
    $ALUR
    $ATOS
    $BRC

    CompanyDatePrice TargetRatingAnalyst
    Plexus Corp.
    $PLXS
    10/24/2025$150.00Buy → Neutral
    Sidoti
    Graham Corporation
    $GHM
    10/21/2025Outperform → Market Perform
    Noble Capital Markets
    NN Inc.
    $NNBR
    7/31/2025$4.00Buy
    B. Riley Securities
    Plexus Corp.
    $PLXS
    7/25/2025$150.00Neutral → Buy
    Sidoti
    Alamos Gold Inc.
    $AGI
    7/9/2025Buy
    Stifel
    Graham Corporation
    $GHM
    7/2/2025$65.00Buy
    Maxim Group
    Graham Corporation
    $GHM
    6/23/2025$55.00Outperform
    Northland Capital
    CSW Industrials Inc.
    $CSWI
    2/14/2025$362.00Hold
    Truist
    More analyst ratings

    $AGI
    $ALUR
    $ATOS
    $BRC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GoHealth Prioritizes Retention, Quality, and Strategic Flexibility as Medicare Advantage Market Rationalizes; Reports Third Quarter 2025 Results

    CHICAGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three and nine months ended September 30, 2025. The Company navigated a materially different Medicare Advantage environment by intentionally reducing Medicare Advantage volume, conserving liquidity, and preserving the core capabilities required to scale when market conditions stabilize. Based on our analysis, health plans continue to emphasize margin integrity, renewal stability, and long-term member value over raw enrollment growth. GoHealth anticipated this shi

    11/13/25 7:00:00 AM ET
    $GOCO
    Specialty Insurers
    Finance

    Atossa Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

    Company reports progress to file planned IND for (Z)-endoxifen in mBC with CRO selection and streamlined development programs for potential 2026-NDA enabling activities, including a Type C meeting with the FDA, to potentially accelerate (Z)-endoxifen in breast cancer risk reduction Appointed key leadership to drive (Z)-endoxifen development and evolve pathway to commercialization SEATTLE, Nov. 12, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing proprietary innovative medicines in areas of significant unmet medical need in oncology, today announces its financial results for the third quarter ended Sep

    11/12/25 8:15:00 AM ET
    $ATOS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Allurion Reports Third Quarter 2025 Financial Results and Provides Business Update

    Allurion Technologies, Inc. (NYSE:ALUR), a pioneer in metabolically healthy weight loss, today announced its financial results for the third quarter and provided a business update. Recent Company Highlights Successfully passed U.S. Food and Drug Administration ("FDA") Pre-Approval Inspection and Bioresearch Monitoring (BIMO) audit with zero observations and no Form 483 issued Completed Premarket Approval ("PMA") Acceptance and Filing Reviews, entered Substantive Review for the Allurion Smart Capsule and successfully completed Day-100 meeting Entered into transaction to exchange all outstanding debt for convertible preferred equity and concurrently announced private placement fina

    11/12/25 8:00:00 AM ET
    $ALUR
    Medical/Dental Instruments
    Health Care

    $AGI
    $ALUR
    $ATOS
    $BRC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Haines Kathleen C

    4 - GENCO SHIPPING & TRADING LTD (0001326200) (Issuer)

    11/12/25 9:00:18 PM ET
    $GNK
    Marine Transportation
    Consumer Discretionary

    Exec VP & COO Mihm Oliver K. sold $255,405 worth of shares (1,748 units at $146.11), decreasing direct ownership by 8% to 19,207 units (SEC Form 4)

    4 - PLEXUS CORP (0000785786) (Issuer)

    11/12/25 4:24:59 PM ET
    $PLXS
    Electrical Products
    Technology

    Exec VP, CAO, Gen Coun & Secy Ninivaggi Angelo Michael Jr sold $363,193 worth of shares (2,500 units at $145.28), decreasing direct ownership by 11% to 20,895 units (SEC Form 4)

    4 - PLEXUS CORP (0000785786) (Issuer)

    11/12/25 4:25:05 PM ET
    $PLXS
    Electrical Products
    Technology

    $AGI
    $ALUR
    $ATOS
    $BRC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Plexus downgraded by Sidoti with a new price target

    Sidoti downgraded Plexus from Buy to Neutral and set a new price target of $150.00

    10/24/25 8:46:54 AM ET
    $PLXS
    Electrical Products
    Technology

    Graham downgraded by Noble Capital Markets

    Noble Capital Markets downgraded Graham from Outperform to Market Perform

    10/21/25 9:21:13 AM ET
    $GHM
    Industrial Machinery/Components
    Industrials

    B. Riley Securities initiated coverage on NN Inc with a new price target

    B. Riley Securities initiated coverage of NN Inc with a rating of Buy and set a new price target of $4.00

    7/31/25 7:18:54 AM ET
    $NNBR
    Industrial Machinery/Components
    Industrials

    $AGI
    $ALUR
    $ATOS
    $BRC
    SEC Filings

    View All

    GoHealth Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - GoHealth, Inc. (0001808220) (Filer)

    11/13/25 7:03:48 AM ET
    $GOCO
    Specialty Insurers
    Finance

    SEC Form 424B3 filed by Allurion Technologies Inc.

    424B3 - ALLURION TECHNOLOGIES, INC. (0001964979) (Filer)

    11/12/25 4:34:33 PM ET
    $ALUR
    Medical/Dental Instruments
    Health Care

    SEC Form 424B3 filed by Allurion Technologies Inc.

    424B3 - ALLURION TECHNOLOGIES, INC. (0001964979) (Filer)

    11/12/25 4:30:56 PM ET
    $ALUR
    Medical/Dental Instruments
    Health Care

    $AGI
    $ALUR
    $ATOS
    $BRC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Gregorio Mauro bought $58,812 worth of shares (1,200 units at $49.01) (SEC Form 4)

    4 - GRAHAM CORP (0000716314) (Issuer)

    9/15/25 4:26:30 PM ET
    $GHM
    Industrial Machinery/Components
    Industrials

    President & CEO Quay Steven C bought $9,887 worth of shares (11,239 units at $0.88), increasing direct ownership by 423% to 13,898 units (SEC Form 4)

    4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)

    5/22/25 6:27:25 PM ET
    $ATOS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Gaur Shantanu bought $24,484 worth of shares (8,000 units at $3.06), increasing direct ownership by 100% to 16,000 units (SEC Form 4)

    4 - ALLURION TECHNOLOGIES, INC. (0001964979) (Issuer)

    5/21/25 4:15:08 PM ET
    $ALUR
    Medical/Dental Instruments
    Health Care

    $AGI
    $ALUR
    $ATOS
    $BRC
    Leadership Updates

    Live Leadership Updates

    View All

    Atossa Appoints Mark Daniel, CPA, as Chief Financial Officer to Lead Finance, Systems, and Capital Strategy for Commercial Readiness

    25+ year life-sciences finance leader brings revenue-forecasting rigor, public-company controls, and capital-markets experience as Atossa prepares for commercial operations with (Z)-endoxifen SEATTLE, Oct. 14, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing new approaches in breast cancer treatment and prevention, announces the appointment of Mark Daniel, CPA (WA; inactive), as Chief Financial Officer. Mr. Daniel is a senior finance leader with more than 25 years of experience building the forecasting cadence, systems, and public-company discipline that support revenue scale in global life-science

    10/14/25 8:00:00 AM ET
    $ATOS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NN, Inc. Appoints Gregg Cottage as Chief Information Officer and CISO

    CHARLOTTE, N.C., Oct. 01, 2025 (GLOBE NEWSWIRE) -- NN, Inc. (NASDAQ:NNBR), a global diversified industrial company that engineers and manufactures high-precision components and assemblies, has announced the promotion of Gregg Cottage to serve as its new Chief Information Officer and Chief Information Security Officer. In this position, Mr. Cottage leads the Company's information technology function, including its enterprise information security strategy. Mr. Cottage will report to Chris Bohnert, Senior Vice President and Chief Financial Officer. Chris Bohnert, Senior Vice President and Chief Financial Officer of NN, commented, "We are pleased to announce Gregg's promotion, which will help

    10/1/25 4:15:00 PM ET
    $NNBR
    Industrial Machinery/Components
    Industrials

    Atossa Therapeutics Names Janet R. Rea, MSPH, as Senior Vice President, R&D to Accelerate (Z)-Endoxifen Toward Key Regulatory Milestones

    Veteran development leader with successful regulatory approvals record returns to lead late-stage clinical and regulatory programs to address multiple unmet clinical needs SEATTLE, Oct. 1, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (NASDAQ:ATOS, ", Atossa", or the ", Company", )), a clinical-stage biopharmaceutical company developing new approaches in breast cancer treatment and prevention, announces the appointment of Janet R. Rea, MSPH to its newly created position Senior Vice President, R&D.  Ms. Rea brings more than two decades of strategic research and clinical development expertise, with a success record for regulatory approvals, to oversee late-stage (Z)-endoxifen programs with ne

    10/1/25 8:30:00 AM ET
    $ATOS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGI
    $ALUR
    $ATOS
    $BRC
    Financials

    Live finance-specific insights

    View All

    GoHealth Prioritizes Retention, Quality, and Strategic Flexibility as Medicare Advantage Market Rationalizes; Reports Third Quarter 2025 Results

    CHICAGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three and nine months ended September 30, 2025. The Company navigated a materially different Medicare Advantage environment by intentionally reducing Medicare Advantage volume, conserving liquidity, and preserving the core capabilities required to scale when market conditions stabilize. Based on our analysis, health plans continue to emphasize margin integrity, renewal stability, and long-term member value over raw enrollment growth. GoHealth anticipated this shi

    11/13/25 7:00:00 AM ET
    $GOCO
    Specialty Insurers
    Finance

    Allurion Reports Third Quarter 2025 Financial Results and Provides Business Update

    Allurion Technologies, Inc. (NYSE:ALUR), a pioneer in metabolically healthy weight loss, today announced its financial results for the third quarter and provided a business update. Recent Company Highlights Successfully passed U.S. Food and Drug Administration ("FDA") Pre-Approval Inspection and Bioresearch Monitoring (BIMO) audit with zero observations and no Form 483 issued Completed Premarket Approval ("PMA") Acceptance and Filing Reviews, entered Substantive Review for the Allurion Smart Capsule and successfully completed Day-100 meeting Entered into transaction to exchange all outstanding debt for convertible preferred equity and concurrently announced private placement fina

    11/12/25 8:00:00 AM ET
    $ALUR
    Medical/Dental Instruments
    Health Care

    GoHealth to Announce Third Quarter 2025 Results on November 13, 2025

    CHICAGO, Nov. 11, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced that the company will release its third quarter 2025 financial results on the morning of November 13, 2025. Chief Executive Officer, Vijay Kotte, and Chief Financial Officer, Brendan Shanahan, will host a conference call and live audio webcast on the day of the release at 8:00 a.m. (ET) to discuss the results. A live audio webcast of the conference call will be available via GoHealth's Investor Relations website, https://investors.gohealth.com/. A replay of the call will be available via webcast for on-demand lis

    11/11/25 9:00:00 AM ET
    $GOCO
    Specialty Insurers
    Finance

    $AGI
    $ALUR
    $ATOS
    $BRC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Citius Pharmaceuticals Inc.

    SC 13D/A - Citius Pharmaceuticals, Inc. (0001506251) (Subject)

    11/27/24 4:05:31 PM ET
    $CTXR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Meihua International Medical Technologies Co. Ltd.

    SC 13G - Meihua International Medical Technologies Co., Ltd. (0001835615) (Subject)

    11/14/24 6:08:55 PM ET
    $MHUA
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Allurion Technologies Inc.

    SC 13G/A - ALLURION TECHNOLOGIES, INC. (0001964979) (Subject)

    11/14/24 4:43:43 PM ET
    $ALUR
    Medical/Dental Instruments
    Health Care